Your browser doesn't support javascript.
loading
[Methoxypolyethylene glycol-modified HLA-A2 antigen on lymphocytes].
Zhang, Yin-ze; Li, Wei; Zhou, Hua-you; Shan, Xiao-yan; Lan, Jiong-cai; Zhang, Yang-pei; Zhang, Zi-xin.
Afiliação
  • Zhang YZ; Department of Blood Transfusion, First Military Medical University, Guangzhou 510515, China. zyz200157@sohu.com
Di Yi Jun Yi Da Xue Xue Bao ; 23(6): 557-60, 2003 Jun.
Article em Zh | MEDLINE | ID: mdl-12810374
ABSTRACT

OBJECTIVE:

To modify the HLA-A2 antigen on the lymphocytes with methoxypolyethylene glycol (mPEG) so as to block the specific binding site for antibody.

METHOD:

Different types of mPEG (all with final concentration of 12 mmol/L) were used at different temperatures in PBS with varied pH values for the modification of the HLA-A2 antigen.

RESULT:

The modification of the antigen was not obviously affected when it was carried out at 4 degrees Celsius or room temperature, but higher temperatures of 30 and 37 degrees Celsius significantly hampered the modification. Better antigen modification was observed with high-concentration mPEG in basic PBS, depending also on the type of mPEGs used for this purpose.

CONCLUSION:

The specific HLA-A2 binding on the lymphocytes is completely blocked by benzotriazole carbonate-mPEG(mPEG-BTC), which is superior to N-hydroxysuccinimidyl ester of mPEG(mPEG-SPA). Maleimide-mPEG(mPEG-MAL) is incapable of blocking the HLA-A2 ligand-binding site with antibody.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Linfócitos / Antígeno HLA-A2 Limite: Humans Idioma: Zh Ano de publicação: 2003 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Linfócitos / Antígeno HLA-A2 Limite: Humans Idioma: Zh Ano de publicação: 2003 Tipo de documento: Article